StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
109
This month
3
This year
13
Publishing Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 05 - 03
2
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
2021 - 01 - 05
1
Sector
Finance
6
Finance and insurance
4
Health technology
109
Manufacturing
1
Tags
Aml
1
Antibody
2
Asco
1
Blood
1
Business
8
Cancer
4
Candidate
2
Cell
3
Change
1
Clearance
1
Clinical-trials-phase-ii
5
Clinical-trials-phase-iii
2
Collaboration
2
Conference
27
Covid
1
Covid-19
1
Designation
1
Disease
1
Drug
4
Earnings
10
Europe
13
Events
24
Expansion
2
Fast track designation
1
Fda
2
Financial
11
Financial results
4
First
1
Growth
1
Iph45
2
Iph5201
2
Iph6101
4
Iph6401
1
Iph6501
1
License
1
Market
1
Meeting
1
Money
2
N/a
27
Natural
2
News
1
Ongoing
1
Payment
1
Pharma
96
Pharmaceutical
15
Phase 2
5
Platform
2
Preclinical
2
Presentation
3
Program
3
Regulatory
5
Report
5
Research
3
Results
18
Sanofi
6
Study
3
Trial
10
Universal
2
Update
15
Year
4
Entities
Abbvie inc.
1
Amgen inc.
1
Argenx se
1
Astellas pharma inc
1
Astrazeneca plc
4
Biogen inc.
1
Bnp paribas
4
Bristol-myers squibb company
2
Denali therapeutics inc.
1
Eli lilly and company
1
Glaxosmithkline plc
1
Incyte corporation
1
Innate pharma s.a.
120
Innate pharma sa
80
Johnson & johnson
1
Morgan stanley
1
Novartis ag
1
Novo nordisk a/s
71
Sanofi
109
Svb financial group
1
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
1
Vertex pharmaceuticals incorporated
1
Zai lab limited
1
Symbols
ABBV
211
ABT
250
ALNY
78
ALPMF
70
ALPMY
70
AMGN
170
AMRN
30
AZN
213
AZNCF
173
BAX
45
BDX
34
BHC
30
BIIB
53
BMRN
29
BMY
119
BNTX
167
BSX
25
BY
26
CMXHF
22
FNCTF
49
GILD
64
GLAXF
270
GLPG
35
GLPGF
35
GOOG
31
GOOGL
31
GSK
334
IGMS
37
INCY
121
IPHA
109
IPHYF
81
JNJ
567
KPTI
25
KYMR
29
LLY
335
MDT
45
MOBV
65
MOR
35
MPSYF
32
MRNA
34
NKTR
42
NVO
139
NVS
329
NVSEF
284
OCX
31
PFE
153
PRGO
110
PRVB
283
PTCT
31
RCFA
83
REGN
254
RLYB
30
SNY
4533
SNYNF
3591
TAK
59
TEVJF
224
TMO
43
TXMD
30
VTRS
87
VXRT
32
Exchanges
Nasdaq
109
Nyse
73
Crawled Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 05 - 03
2
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
2021 - 01 - 05
1
Crawled Time
05:00
2
06:00
22
07:00
22
08:00
19
09:00
18
10:00
8
11:00
10
12:00
5
12:30
1
22:00
1
23:00
1
Source
www.biospace.com
82
www.globenewswire.com
26
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Sanofi
symbols :
Ipha
save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published:
2024-04-10
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-2.99%
|
O:
-0.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-7.31%
|
O:
-3.85%
H:
1.2%
C:
0.8%
iph45
pharma
drug
candidate
antibody
preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published:
2024-04-09
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-1.38%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-2.56%
|
O:
-0.38%
H:
0.95%
C:
0.83%
IPHA
|
$2.41
11K
|
Health Technology
|
-3.21%
|
O:
2.57%
H:
1.81%
C:
1.81%
pharma
conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published:
2024-04-05
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-5.11%
|
O:
-3.44%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-3.6%
|
O:
-0.4%
H:
0.0%
C:
-5.22%
pharma
report
universal
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published:
2024-03-21
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-2.56%
|
O:
0.3%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-3.6%
|
O:
-4.51%
H:
4.25%
C:
0.96%
pharma
business
year
update
financial
results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published:
2024-03-19
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-2.31%
|
O:
-0.02%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-4.0%
|
O:
-1.51%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
0.84%
|
O:
0.84%
H:
4.56%
C:
0.83%
pharma
conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-4.57%
|
O:
0.23%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-3.6%
|
O:
-2.4%
H:
3.69%
C:
3.28%
pharma
conference
year
financial
results
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published:
2024-03-06
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-3.03%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-6.23%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph6501
first
study
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published:
2024-03-06
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-3.03%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-6.23%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph45
pharma
drug
antibody
preclinical
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published:
2024-02-21
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-1.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-2.72%
|
O:
-0.57%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-6.95%
|
O:
-2.32%
H:
0.0%
C:
0.0%
pharma
conference
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
$140.15
560
|
Health Technology
|
12.13%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.46
500K
|
Manufacturing
|
-13.68%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
$13.215
0.49%
210K
|
Health Technology
|
-8.11%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$92.61
-0.51%
430K
|
Health Technology
|
-7.41%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$144.86
0.06%
2.8M
|
Health Technology
|
-7.56%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
$39.44
-0.4%
560K
|
Health Technology
|
-3.58%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$749.245
-0.2%
550K
|
Health Technology
|
1.83%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.145
0.64%
2.5M
|
Health Technology
|
-2.99%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$167.2
1.8%
1.3M
|
Health Technology
|
-5.28%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.12
2.92%
180K
|
Health Technology
|
-24.66%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$393.86
0.19%
160K
|
Health Technology
|
-6.08%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-0.19%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-6.59%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.46
-0.49%
330K
|
Health Technology
|
-8.85%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$191.72
-0.23%
370K
|
Health Technology
|
-20.26%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
$68.635
0.15%
1.3M
|
Health Technology
|
11.16%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$366.93
0.2%
85K
|
Health Technology
|
-5.61%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$265.48
0.53%
360K
|
Health Technology
|
-9.34%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published:
2024-01-12
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-11.9%
|
O:
0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-13.62%
|
O:
0.0%
H:
0.36%
C:
0.36%
pharma
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published:
2024-01-04
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-7.89%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.41
11K
|
Health Technology
|
-13.31%
|
O:
6.47%
H:
3.65%
C:
-2.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published:
2024-01-04
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-7.89%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.41
11K
|
Health Technology
|
-13.31%
|
O:
6.47%
H:
3.65%
C:
-2.36%
fda
pharma
program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$123.37
-0.93%
1.4M
|
Health Technology
|
25.81%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-4.83%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-1.63%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published:
2023-12-18
(Crawled : 10:00)
- biospace.com/
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-3.64%
|
O:
1.25%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
0.0%
|
O:
2.9%
H:
2.02%
C:
-1.21%
pharma
change
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published:
2023-12-11
(Crawled : 08:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
11.81%
|
O:
9.45%
H:
0.0%
C:
-1.7%
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-0.54%
|
O:
0.5%
H:
1.67%
C:
0.1%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-0.22%
|
O:
2.15%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-6.59%
|
O:
-1.16%
H:
0.39%
C:
-4.31%
sar4435
pharma
iph6101
cell
results
sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published:
2023-11-27
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-2.62%
|
O:
-0.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-2.12%
|
O:
1.04%
H:
0.17%
C:
0.11%
IPHA
|
$2.41
11K
|
Health Technology
|
-0.41%
|
O:
2.07%
H:
1.21%
C:
1.21%
pharma
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published:
2023-11-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
1.61%
|
O:
0.68%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
6.17%
|
O:
6.61%
H:
9.39%
C:
6.61%
pharma
business
update
financial
results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published:
2023-11-07
(Crawled : 08:00)
- biospace.com/
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
0.95%
|
O:
-1.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-7.31%
|
O:
-2.31%
H:
2.76%
C:
1.18%
pharma
conference
business
update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published:
2023-10-27
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
1.4K
|
Health Technology
|
-11.93%
|
O:
-18.18%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.445
-1.44%
2.6M
|
Health Technology
|
-13.23%
|
O:
-15.73%
H:
0.0%
C:
0.0%
IPHA
|
$2.41
11K
|
Health Technology
|
-2.03%
|
O:
-2.85%
H:
12.13%
C:
3.77%
pharma
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
82%
18%
Top 10 Gainers
AGBA
|
$0.7995
99.88%
73M
|
Finance
BPTH
|
$6.21
91.67%
58M
|
Health Technology
INVO
|
$1.36
78.95%
3.6M
|
Health Technology
TIRX
|
$0.8258
70.34%
50M
|
ISPC
|
$0.307
44.13%
3.6M
|
Professional, Scientific, and T...
SINT
|
$0.0519
39.14%
350M
|
Health Technology
VTNR
S
|
$1.295
32.25%
5.5M
|
Industrial Services
ALRN
|
$5.53
30.12%
250K
|
Health Technology
HOLO
|
$2.86
27.68%
28M
|
XPON
|
$2.43
25.91%
7.2M
|
Your saved searches
Save your searches and get alerts when important news are released.